ABSTRACT
PURPOSE: The evaluation of latent tuberculosis infection (LTBI) is recommended before kidney transplantation. The interferon-γ release assay has been reported to be more specific than the tuberculin skin test (TST) for detecting LTBI. We compared the TST and QuantiFERON-TB Gold In-Tube test (QFT-GIT) for the screening for LTBI and determined the agreement between the two tests in renal transplant recipients before transplantation. METHODS: Adult patients who were evaluated for renal transplantation between May 2010 and February 2012 at Severance Hospital in South Korea were prospectively enrolled. We performed TST and QFT-GIT. RESULTS: Of the 126 patients, 23 (19.3 %) had positive TST results and 53 (42.1 %) had positive QFT-GIT results. Agreement between the TST and QFT-GIT was fair (κ = 0.26, P < 0.001). The induration size of TST was significantly correlated with a positive rate of QFT-GIT (P = 0.015). Age (odds ratio [OR] 1.08, 95 % confidence interval [CI] 1.03-1.13, P = 0.003), male sex (OR 2.73, 95 % CI 1.17-6.38, P = 0.021), and risk for LTBI (OR 4.62, 95 % CI 1.15-18.64, P = 0.031) were significantly associated with positive QFT-GIT results. For positive TST results, only male sex was associated (OR 4.29, 95 % CI 1.40-13.20, P = 0.011). CONCLUSION: The positivity for QFT-GIT was higher than the positivity for TST, and QFT-GIT more accurately reflected the risk for LTBI. However, a further longitudinal study is needed in order to confirm that the QFT-GIT test can truly predict the development of TB after renal transplantation.
Subject(s)
Interferon-gamma Release Tests , Latent Tuberculosis/diagnosis , Tuberculin Test , Adult , Aged , Female , Humans , Kidney Transplantation , Male , Middle Aged , Reproducibility of Results , Republic of Korea , Sensitivity and Specificity , Young AdultABSTRACT
Endograft mal-deployment during endovascular aneurysm repair (EVAR) may cause renal artery (RA) occlusion. We report bilateral RA occlusion following insertion of an endograft with suprarenal barb fixation. Attempted salvage using the 'pull-down' technique caused right RA dissection. Despite bilateral RA stenting, the right kidney was atrophic on an ultrasound scan at 6 months. This potential hazard of devices with suprarenal barb fixation should be considered when repositioning is attempted.
Subject(s)
Aortic Aneurysm, Abdominal/surgery , Aortic Dissection/etiology , Blood Vessel Prosthesis Implantation/instrumentation , Blood Vessel Prosthesis , Endovascular Procedures/instrumentation , Kidney/blood supply , Renal Artery Obstruction/etiology , Stents , Aged , Aortic Dissection/diagnostic imaging , Aortic Aneurysm, Abdominal/diagnostic imaging , Atrophy , Blood Vessel Prosthesis Implantation/adverse effects , Endovascular Procedures/adverse effects , Female , Humans , Hypertrophy , Kidney/diagnostic imaging , Prosthesis Design , Radiography , Renal Artery Obstruction/diagnostic imaging , Renal Artery Obstruction/surgery , Renal Circulation , Reoperation , Time Factors , UltrasonographyABSTRACT
Fifty-four quinupristin/dalfopristin-resistant Enterococcus faecium (QDREF) isolated from chickens and pigs during 2002-2003 in Korea were screened by PCR for the presence of streptogramin resistance genes vatD, vatE, and vgbA, and macrolide resistance gene ermB. None of the QDREF isolates carried vgbA and vatD genes, while vatE and ermB were detected in 9.2% and 74% of the isolates, respectively. Twenty-six percent (14/54) of the QDREF isolates contained none of the resistance determinants tested. Pulsed-field gel electrophoresis (PFGE) patterns revealed high heterogeneity: 47 different patterns for 54 QDREF evaluated. Identical PFGE types were observed in two pairs of chicken isolates and a pair of pig isolates, respectively, but chicken isolates did not share PFGE pattern with pig isolates, suggesting clonal spread of QDREF strain between the same species of animals but not between different species of animals. This is the first report, to our knowledge, of vatE-positive E. faecium isolates and also the first evidence of clonal spread of QDREF strain between animals in Korea.
Subject(s)
Drug Resistance, Multiple, Bacterial , Enterococcus faecium/drug effects , Enterococcus faecium/genetics , Streptogramins/pharmacology , Virginiamycin/pharmacology , Animals , Anti-Bacterial Agents/pharmacology , Chickens , Gram-Positive Bacterial Infections/epidemiology , Gram-Positive Bacterial Infections/microbiology , Gram-Positive Bacterial Infections/veterinary , Korea/epidemiology , Poultry Diseases/epidemiology , Poultry Diseases/microbiology , Swine , Swine Diseases/epidemiology , Swine Diseases/microbiologyABSTRACT
BACKGROUND AND STUDY AIMS: It is known that metal stent placement is safe, easy, and effective for the treatment of malignant colorectal obstruction, but these stents are associated with delayed complications of tumor ingrowth and stent migration. The aim of this study was to prospectively investigate the technical feasibility, clinical effectiveness, and safety of a dual-design colorectal stent (consisting of an outer stent and an inner bare nitinol stent) in patients with malignant colorectal obstruction. PATIENTS AND METHODS: Placement of the dual stent using a 4.5-mm stent delivery system was attempted in 151 patients with malignant colorectal obstruction, either before surgery (n = 50) or for palliation (n = 101). Multivariate logistic regression analysis was used to identify risk factors associated with complications. RESULTS: Stent placement was technically successful in 145/151 patients (96%). Of the patients who had a technically successful placement, bowel obstruction resolved within 2 days after stent placement in 48/50 (96%) of the patients in the bridge-to-surgery group and in 87/95 (92%) of the patients in the palliative group. Perforation occurred in 16 patients, incomplete stent expansion in eight patients, stent migration in four patients, tumor overgrowth in five patients, severe rectal pain in five patients, and bleeding in eight patients. Complete obstruction was the only significant risk factor for perforation (odds ratio 6.88, 95% CI 2.04-23.17, P = 0.002). In the palliative group, the median survival was 152.0 days and the mean survival was 263.8 days. CONCLUSIONS: The dual stent with a 4.5-mm stent delivery system is easy to insert, safe, and reasonably effective for the palliative treatment of malignant colorectal obstruction. However, a great deal of care is needed in its deployment because of the high rate of perforation.
Subject(s)
Colorectal Neoplasms/complications , Intestinal Obstruction/therapy , Stents , Adolescent , Adult , Aged , Aged, 80 and over , Equipment Design , Female , Follow-Up Studies , Foreign-Body Migration/etiology , Humans , Intestinal Obstruction/etiology , Intestinal Obstruction/mortality , Intestinal Perforation/etiology , Male , Middle Aged , Multivariate Analysis , Pain/etiology , Palliative Care , Prospective Studies , Stents/adverse effects , Survival RateABSTRACT
PURPOSE: To assess the safety and clinical effectiveness of the parallel placement of covered retrievable expandable metallic stents in the palliative treatment of malignant esophageal and tracheobronchial strictures. MATERIAL AND METHODS: Under fluoroscopic guidance, parallel stents were placed in 12 symptomatic patients with both malignant esophageal and tracheobronchial strictures. Seven of these 12 patients also had an esophagorespiratory fistula (ERF) and one patient had an esophagocutaneous fistula. Technical success, clinical improvement, complications, and survival rates were evaluated. RESULTS: A total of 28 esophageal and airway stents were successfully placed. The grade of dysphagia and dyspnea score significantly decreased after stent placement (P=0.002 and 0.003, respectively). ERF and esophagocutaneous fistula were sealed off in all eight patients after esophageal stent placement; however, the esophagocutaneous fistula reopened 1 month later. Complications included stent migration or expectoration (n=3), tracheal compression by the esophageal stent (n=3), new fistula development due to covering membrane degradation of the esophageal stent (n=1), and symptomatic sputum retention (n=1). Stent removal was easily performed for two stents; one migrated stent and the other with covering membrane degradation. All 12 patients died within the mean survival period of 72.50 days (range 7-375 days). CONCLUSION: Parallel placement of covered retrievable expandable metallic stents is safe and effective for the palliative treatment of malignant esophageal and tracheobronchial strictures.
Subject(s)
Alloys/therapeutic use , Bronchial Diseases/therapy , Esophageal Stenosis/therapy , Head and Neck Neoplasms/complications , Lung Neoplasms/complications , Stents , Tracheal Stenosis/therapy , Adult , Aged , Bronchial Diseases/etiology , Bronchial Diseases/mortality , Constriction, Pathologic/etiology , Constriction, Pathologic/mortality , Constriction, Pathologic/therapy , Esophageal Fistula/etiology , Esophageal Fistula/therapy , Esophageal Stenosis/etiology , Esophageal Stenosis/mortality , Esophagus/diagnostic imaging , Esophagus/surgery , Female , Follow-Up Studies , Humans , Male , Middle Aged , Palliative Care/methods , Postoperative Complications , Radiography , Retrospective Studies , Stents/adverse effects , Survival Rate , Trachea/diagnostic imaging , Trachea/surgery , Tracheal Stenosis/etiology , Tracheal Stenosis/mortality , Treatment OutcomeABSTRACT
PURPOSE: To report our experience of endovascular stent-graft placement in patients with descending thoracic aortic dissections and aneurysms and to evaluate the feasibility, safety, and clinical outcomes of the treatment. MATERIALS AND METHODS: Stent-grafts were placed in the descending thoracic aortas of 23 patients with saccular aneurysms (n = 11) and Stanford type B chronic aortic dissections of the descending thoracic and abdominal aorta (n = 12). All stent-grafts were individually constructed of self-expandable stainless steel stents covered with polytetrafluoroethylene. Vascular access was achieved through the femoral artery in all patients. Clinical status of each patient was monitored and postoperative CT was performed within 1 month of the procedure and at 3-12-month intervals after the procedures. RESULTS: Successful exclusion of the primary entry tears of dissections and the inlets of saccular aneurysms was achieved in all but two patients with aortic dissection. The overall technical success rate was 91.3% (dissection: 10 of 12 = 83%; aneurysm: 11 of 11 = 100%). All patients in whom technical success was achieved showed complete thrombosis and significant decrease in diameter of the thoracic false lumen (preoperative: 5.3 cm +/- 0.9; postoperative: 4.3 cm +/- 0.9; P = .004) or aneurysm sac (preoperative: 5.3 cm +/- 1.7; postoperative: 2.8 cm +/- 2.5; P = .001). In addition, five patients demonstrated complete resolution of the dissected thoracic false lumen (n = 2) and aneurysm sac (n = 3). However, in all patients with aortic dissection, the abdominal aorta was not significantly changed in size (P = .302) and shape and their false lumen flows remained persistent. Immediate postoperative complications were detected in 12 patients (52%); 10 had fever, leukocytosis, and elevation of C-reactive protein, another had wound infection, and another had transient abdominal pain. Three patients died 2, 3, and 12 months after the procedure: one from septic shock, another from underlying mediastinitis, and the other from an unexplained cause. The remaining 20 patients were well after the procedure (1-9 days; mean, 3 days), without any stent-graft-related complications or discomfort (follow up period: 10-65 mo; mean: 25.1 mo +/- 15.6). The cumulative survival rate after the stent graft was 100% at 30 days and 91% at 12 months. CONCLUSIONS: For treatment of aortic dissection and saccular aneurysm of the descending thoracic aorta, endovascular stent-graft repair may be a technically feasible and effective treatment modality.
Subject(s)
Aortic Aneurysm, Thoracic/surgery , Aortic Dissection/surgery , Blood Vessel Prosthesis , Stents , Adult , Aged , Aortic Dissection/mortality , Angiography, Digital Subtraction , Aortic Aneurysm, Thoracic/mortality , Aortography , Chronic Disease , Female , Femoral Artery/surgery , Humans , Male , Middle Aged , Postoperative Complications , Tomography, X-Ray Computed , Treatment OutcomeABSTRACT
PURPOSE: To investigate the technical feasibility and clinical effectiveness of a polyurethane-covered expandable nitinol stent in the treatment of malignant gastroduodenal obstructions. MATERIALS AND METHODS: The stent was constructed in-house by weaving a single thread of 0.2-mm nitinol wire in a tubular configuration and was covered with polyurethane solution by means of a dipping method. With fluoroscopic guidance, the stent was placed in 19 consecutive patients with malignant gastric outlet obstruction (n = 15) or duodenal obstruction (n = 4). All patients had severe nausea and recurrent vomiting, and their obstructions were inoperable. RESULTS: Stent placement was technically successful in all but one patient. After stent placement, symptoms improved in all but one patient, who had another stenosis at the proximal jejunum. One patient with stent placement in the second portion of the duodenum became jaundiced. During the mean follow-up of 11 weeks, stent migration occurred in five patients 1-4 days after the procedure. All patients with stent migration were treated by means of placing a second, uncovered nitinol stent. Two of these five patients showed recurrence of stricture because of tumor ingrowth; they underwent coaxial placement of a third, covered nitinol stent with good results. CONCLUSION: Placement of a polyurethane-covered expandable nitinol stent seems to be technically feasible and effective for palliative treatment of inoperable malignant gastroduodenal obstructions. Stent migration, however, is problematic and requires further investigation.
Subject(s)
Coated Materials, Biocompatible , Duodenal Neoplasms/therapy , Duodenal Obstruction/therapy , Gastric Outlet Obstruction/therapy , Palliative Care , Pancreatic Neoplasms/therapy , Pyloric Stenosis/therapy , Stents , Stomach Neoplasms/therapy , Adult , Aged , Aged, 80 and over , Alloys , Duodenal Neoplasms/diagnostic imaging , Duodenal Obstruction/diagnostic imaging , Duodenal Obstruction/etiology , Feasibility Studies , Female , Gastric Outlet Obstruction/diagnostic imaging , Gastric Outlet Obstruction/etiology , Humans , Male , Middle Aged , Pancreatic Neoplasms/diagnostic imaging , Polyurethanes , Prosthesis Design , Prosthesis Failure , Pyloric Stenosis/diagnostic imaging , Pyloric Stenosis/etiology , Radiography , Stomach Neoplasms/diagnostic imagingABSTRACT
The overall success of orthotopic liver transplantation (OLTX) includes not only survival, but quality of life (QOL) as well. We studied one controversial group of OLTX recipients, patients transplanted for alcoholic liver disease (Laennec's), to determine if their post-OLTX QOL was similar to that of patients transplanted for non-alcoholic liver disease (non-Laennec's). Over a 10-yr period, patients undergoing OLTX at our institution were asked to complete a QOL questionnaire addressing a wide range of topics from demographics and employment to symptom distress/frequency, activities of daily living, and effect of loss of health on daily life. Twenty-four Laennec's and 100 non-Laennec's OLTX recipients completed the questionnaire at both their 2- and 5-yr follow-up visits at our institution. Both groups were well-matched in age, race, and patient location status at the time of OLTX. No significant differences could be detected between Laennec's and non-Laennec's scores regarding overall QOL, including one's ability to function, health perception, and self-perception at 2 and 5 years post-OLTX, and between 2 and 5 years post-OLTX. Although not between groups, a significant difference was noted regarding patients' satisfaction with life, with less satisfaction reported at the 5-yr versus the 2-yr time point post-OLTX. Rates of current/recent employment between both groups were also similar at 2 years post-OLTX, and again at 5 years post-OLTX. We conclude that overall QOL and employment levels appear similar between patients transplanted for alcoholic and non-alcoholic liver disease. This similarity appears to extend to 5 years post-OLTX.
Subject(s)
Liver Diseases, Alcoholic/surgery , Liver Failure/surgery , Liver Transplantation/psychology , Quality of Life , Activities of Daily Living , Analysis of Variance , Attitude to Health , Case-Control Studies , Employment , Female , Follow-Up Studies , Health Status , Humans , Liver Diseases, Alcoholic/physiopathology , Liver Failure/physiopathology , Liver Transplantation/physiology , Male , Middle Aged , Personal Satisfaction , Self Concept , Surveys and Questionnaires , Treatment OutcomeABSTRACT
A polyurethane-covered retrievable expandable stent was placed in 13 patients with tracheobronchial strictures. In four patients with benign strictures, the stent was removed with use of a retrieval hook 2-6 months after placement. After stent removal, three of the four patients did not need further treatment. The retrievable stent warrants further investigation in the treatment of tracheobronchial strictures.
Subject(s)
Airway Obstruction/therapy , Alloys , Bronchial Diseases/therapy , Coated Materials, Biocompatible , Polyurethanes , Stents , Tracheal Stenosis/therapy , Adult , Aged , Device Removal , Equipment Design , Equipment Failure Analysis , Female , Humans , Male , Middle AgedABSTRACT
In the present study, we examined the modulation of heat shock factor 1 (HSF1) activity and expression of heat shock proteins (HSPs) after exposure to anticancer drugs. Anticancer drugs induced HSF1 DNA-binding activity, and this was followed by an increase of mitochondrial HSP75 and HSP60 levels and concurrent decrease of cytoplasmic HSP70 levels. Unlike heat shock-induced full phosphorylation, HSF1 was partially phosphorylated after exposure to vincristine, and this result was tightly correlated with the kinetics of JNK/SAPK activation, and up-regulation of mitochondrial HSP75 level and concurrent down-regulation of HSP70. Furthermore, the dominant-negative mutant of SEK1 blocked the phosphorylation of HSF1 and up-regulation of mitochondrial HSP75 in response to vincristine or vinblastine. These data suggest that anticancer drugs regulate the HSF1 transcriptional activity differently from heat shock, and JNK/SAPK pathway appears to be involved in anticancer drug-induced HSF1 phosphorylation and consequently differential regulation of mitochondrial HSP75 and HSP60 and cytoplasmic HSP70.
Subject(s)
Antineoplastic Agents/pharmacology , Calcium-Calmodulin-Dependent Protein Kinases/metabolism , DNA-Binding Proteins/metabolism , Heat-Shock Proteins/metabolism , Mitogen-Activated Protein Kinases , Animals , Bleomycin/pharmacology , Cells, Cultured , Doxorubicin/pharmacology , Heat Shock Transcription Factors , Heat-Shock Response , Humans , JNK Mitogen-Activated Protein Kinases , Mice , Phosphorylation , Protein Binding , Transcription Factors , Vinblastine/pharmacology , Vincristine/pharmacologyABSTRACT
OBJECTIVE: Our objective was to assess the radiographic and CT findings of acute eosinophilic pneumonia. CONCLUSION: Initial and follow-up chest radiographs, chest CT scans (n = 5) and clinical data in six patients with acute eosinophilic pneumonia were reviewed by two chest radiologists. The predominant initial radiographic finding was diffuse bilateral reticular densities (four [67%] of six patients). Areas of ground-glass opacity were observed on CT scans in all patients (5 of 5) and were bilateral, random, and patchy in distribution in four (80%) of five patients. Smooth septal thickening and pleural effusions were observed in four patients. The disease manifested as rapid onset of severe dyspnea and fever and rapid resolution with (n = 3) or without (n = 3) steroid therapy. Bilateral reticular densities on chest radiographs and, on CT scans, ground-glass opacity with smooth septal thickening and pleural effusion associated with acute fever and dyspnea may suggest the diagnosis of acute eosinophilic pneumonia.